Q4 2024 Management View CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds ...

Temple & Webster (ASX: TPW) shares opened 12% higher on Thursday after the company reported a bumper first-half result that ...

RED DIGITAL CINEMA® announced today that its groundbreaking V-RAPTOR [X] and KOMODO-X camera systems will also now be ...